Top Tweets for #ILCS23
Lung cancer diagnostics in discuss the latest insights and guidelines with Anne Schultheis at ILCS24 - @LungSummit
https://t.co/My9xlyHeK8
#Oncology #Cancer #Research #LungCancer #LCSM #ILCS23 #Summit
How can we advance the standard of treatment for those with oncogene-driven #LungCancer? 🫁
An interesting question by @ZPiotrowskaMD for @HendriksLizza and all those at the #ILCS23 conference.
Hear their thoughts below and catch the full discussion online ⬇️
Why do we not have a successful biomarker for TROP2-directed ADCs? 🤔
Hear Dr. Paul Hofman's (@CHUdeNice) thoughts on this from the last #ILCS23 meeting.
Watch the full discussion online to learn more ⬇️
Why do we not have a successful biomarker for TROP2-directed ADCs? 🤔
Hear Dr. Paul Hofman's (@CHUdeNice) thoughts on this from the last #ILCS23 meeting.
Watch the full discussion online to learn more ⬇️
Do circadian rhythms play a role in the pharmacodynamics of immunotherapy in the treatment of #LungCancer? 🤔
Explore this emerging topic with @peters_solange and @charocampelo from the latest #ILCS23 meeting.
Watch the full talk online ⬇️
What is the role of #ctDNA in patient selection for #LungCancer treatment?
Revisit the topic with @APassaroMD and @tnewsomdavis who shared their thoughts on this at the latest #ILCS23.
Watch the full debate online ⬇️
Are multiple immunotherapies necessary for those with non-oncogenic #NSCLC? 🫁
Hear from @HendriksLizza on this topic and much more from the last #ILCS23!
Watch the full talk online ⬇️
What are the challenges in profiling molecular #SCLC subtypes and choosing appropriate treatments? 🫁
Hear from @kaushalpar on this and much more on treatment paradigms for SCLC from the last #ILCS23 ⬇️
Is there a role for metronomic #immunotherapy for those with #lungcancer, especially in low- and middle-income countries (#LMICs)?
Listen to @peters_solange and @charocampelo on this very question, and more from the latest #ILCS23 ⬇️
How should we evaluate the potential benefits of perioperative immunotherapy for those who have undergone one or multiple segmentectomies?
Explore the answer to this question with Jean Yannis Perentes and @peters_solange from the lastest #ILCS23 meeting ⬇️
Are cytoblocks built on cytology reliable for immunohistochemistry?
A great question on a topic of continued debate by tumor boards, from @peters_solange to Paul Hofman at the last #ILCS23.
Listen and watch the full discussion online ⬇️
Is there an argument to choose against adjuvant immunotherapy for a subset of patients with #LungCancer? 🤔
A question from @Timothee_MD to @tnewsomdavis and @APassaroMD at the latest #ILCS23 meeting.
Watch the full discussion online ⬇️
What are the current and future treatment options for those with #SCLC? 🫁
Explore the topic in @kaushalpar's keynote talk from the lastest #ILCS23 meeting.
Watch and download the full presentation online ⬇️
How can we advance the standard of treatment for those with oncogene-driven #LungCancer? 🫁
A great question by @ZPiotrowskaMD for @HendriksLizza and all those at the #ILCS23 conference.
Hear their thoughts below and catch the full discussion online ➡️ https://t.co/Tn2CpEQWpd
Do circadian rhythms play a role in the pharmacodynamics of immunotherapy in the treatment of #LungCancer? 🤔
Explore this emerging topic with @peters_solange and Rosario G. Campelo from the latest #ILCS23 meeting.
Watch the full talk online ➡️ https://t.co/Tn2CpEQWpd
Why do we not have a successful biomarker for TROP2-directed ADCs? 🤔
Hear Dr. Paul Hofman's (@CHUdeNice) thoughts on this from the last #ILCS23 meeting.
Watch the full discussion online to learn more ⬇️
What is the role of #ctDNA in patient selection for #LungCancer treatment? 🧬
Hear @APassaroMD and @tnewsomdavis thought's on this from the latest #ILCS23.
Watch the full debate online ⬇️
This year's #ILCS23 was bigger than ever, uniting minds from 88 countries for a global exchange of ideas and collaboration in #LungCancer research.
Revisit the conference online to catch up on the inspiring talks and discussions ⬇This year's #ILCS23 was bigger than ever, uniting minds from 88 countries for a global exchange of ideas and collaboration in #LungCancer research.
Revisit the conference online to catch up on the inspiring talks and discussions ⬇This year's #ILCS23 was bigger than ever, uniting minds from 88 countries for a global exchange of ideas and collaboration in #LungCancer research.
Revisit the conference online to catch up on the inspiring talks and discussions ⬇️
Listen to @HendriksLizza's take-home messages on new immunotherapeutics for #LungCancer from the latest #ILCS23 💊
Watch and download the full presentation ⬇️
Last Seen Hashtags on Sotwe
พ่อของลูก
Seen from Thailand
nolimit (filter:videos)
Seen from Turkey
CompliancePackaging
Seen from United States
momsonn(*)()
Seen from Netherlands
cum
Seen from Qatar
teenageer
Seen from United States
momsonn()**********************************************
Seen from Australia
omegle()**** filter:native_video()
Seen from Netherlands
ＡＩグラビア
Seen from Korea
grannypanty
Seen from United Kingdom
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.8M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.1M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers